Blood test kit

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a front perspective view of a blood test kit showing the new design.

FIG. 2 is a top plan view thereof.

FIG. 3 is a bottom plan view thereof.

FIG. 4 is a left side view thereof.

FIG. 5 is a right side view thereof.

FIG. 6 is a front end side view thereof; and,

FIG. 7 is a back end side view thereof.

The features shown in broken lines in the drawings depict environmental subject matter only and form no part of the claimed design.

Claims

The ornamental design for a blood test kit, as shown and described.

Referenced Cited
U.S. Patent Documents
5728587 March 17, 1998 Kang
5939331 August 17, 1999 Burd
6239445 May 29, 2001 Shaeef
6267722 July 31, 2001 Anderson
D454398 March 12, 2002 Robertson
D456082 April 23, 2002 Bouse
D467348 December 17, 2002 McMichael
D468437 January 7, 2003 McMenamy
D495805 September 7, 2004 Lea
D500142 December 21, 2004 Crisanti
6855561 February 15, 2005 Jerome
D512512 December 6, 2005 Bell
D531321 October 31, 2006 Godfrey
7285425 October 23, 2007 Shareef
D561344 February 5, 2008 Kozak
7326578 February 5, 2008 Bateman
D602599 October 20, 2009 Xiaowei
7847946 December 7, 2010 Krauth
D639977 June 14, 2011 Francis
D640389 June 21, 2011 Francis
D655424 March 6, 2012 Castanon
D660977 May 29, 2012 Wagner
D660978 May 29, 2012 Wagner
8268636 September 18, 2012 Nazareth
D668350 October 2, 2012 Rowley
D668779 October 9, 2012 Khan
8278109 October 2, 2012 Nazareth
D676570 February 19, 2013 Chance
Other references
  • Sanada, et al.,“IL-33 and ST2 Comprise a Critical Biomechanically Induced and Cardioprotective Signaling System”; The Journal of Clinical Investigation; May 10, 2007.
  • Sanchez-Mas, et al.; “Modulcation of IL-33/ST2 System in Postinfraction Heart Failure: correlation with Cardiac Remodeling Markers”; European Journal of Clinical Investigation; vol. 44; 2014; pp. 643-651.
  • Seki, et al., “Interleukin-33 Prevents Apoptosis and Improves survival After Experimental Myocardial Infarction Through ST2 Signaling”; American Heart Association; Feb. 16, 2010.
Patent History
Patent number: D770057
Type: Grant
Filed: Sep 23, 2014
Date of Patent: Oct 25, 2016
Assignee: Critical Care Diagnostics, Inc. (San Diego, CA)
Inventors: James V. Snider (San Diego, CA), David Geliebter (Palm Beach Gardens, FL)
Primary Examiner: T. Chase Nelson
Assistant Examiner: Mark Cavanna
Application Number: 29/503,093